Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02860845Phase 4Completed

Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections

Role: collaborator

NCT02248948Not ApplicableCompleted

Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children

Role: collaborator

NCT02920411Not ApplicableCompleted

Effectiveness of a Combined Dermatological Treatment in Children With Atopic Dermatitis

Role: collaborator

NCT03539926Not ApplicableUnknown

This Study Evaluates the Superiority of Daily Self-pH Monitorization of Lit-control®pH Meter Compared to the Monitorization of Reactive Strips (Standard of Care).

Role: collaborator

NCT03343275Not ApplicableCompleted

Combined Use of a Medical Device and a Dietary Complement in Patient Urinary pH Control in Patients With an Implanted Double J Stent.

Role: collaborator

All 5 trials loaded